Actively Recruiting

Phase 2
Age: 18Years - 60Years
All Genders
Healthy Volunteers
ID00739362

The Effects of Transcranial Direct Current Stimulation (TDCS) on Food Intake and Weight Loss

Led by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Updated on 2026-05-22

148

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying whether electrical stimulation of a brain area called the left dorsolateral prefrontal cortex (DLPFC), which influences feelings of fullness after eating, can affect food intake and weight loss in obese adults. The study also compares weight changes in people who attend weight loss counseling sessions to those who do not. This research focuses on adults aged 18 to 60 with obesity (BMI of 35 or higher) who do not have diabetes and are generally healthy. Participants stay at the NIH inpatient unit for the first 9 days, undergoing tests such as meal tests, blood and urine analyses, glucose tolerance tests, psychological assessments, and DEXA scans for body fat measurement. Some participants receive active transcranial direct current stimulation (tDCS) on the left DLPFC for 40 minutes, while others receive sham stimulation with little or no current. After discharge, participants follow a diet with 25% fewer calories at home for 4 weeks and visit the NIH unit three times weekly to receive either active or sham tDCS sessions. During the study, participants' food intake, weight change, brain activity measured by functional MRI, and hormone levels related to appetite are monitored. They also complete questionnaires on eating behaviors and stress. Follow-up visits occur at 6 months and 1 year to assess weight changes. The study lasts 9 weeks with outpatient visits three times per week and includes detailed safety monitoring and behavioral assessments throughout.

CONDITIONS

Brief Title

Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

Who Can Participate

Age: 18Years - 60Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Body mass index (BMI) of 25 kg/m2 or higher
  • Age between 18 and 60 years
  • Right-handed
  • Stable weight (within +/- 5%) for the last 3 months
  • Generally healthy and non-diabetic
  • Living in the Phoenix, AZ metropolitan area
Not Eligible

You will not qualify if you...

  • Weight over 300 pounds unless confirmed to fit MRI machine
  • Use of metabolism or appetite-affecting medication in last 3 months
  • Current pregnancy, recent pregnancy within 6 months, or lactation
  • History of disorders affecting appetite or energy use (e.g., diabetes, Cushing's disease, thyroid disorders)
  • Gastrointestinal diseases such as Crohn's disease, ulcerative colitis, celiac disease, or active gastric ulcer
  • Unstable medical conditions like hepatitis, renal insufficiency, recent cancer treatment, or CNS disorders
  • Alcohol abuse (AUDIT score 8 or higher)
  • Drug use including amphetamines, cocaine, heroin, or marijuana
  • Tobacco use exceeding very low dependence
  • Postmenopausal women or symptoms of perimenopause
  • Any contraindications for MRI (e.g., pacemaker, metal in skull, claustrophobia)
  • Any other condition that may interfere with safety or study participation as judged by investigators

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 9 weeks

Participants receive active or sham transcranial direct current stimulation (tDCS) to the left dorsolateral prefrontal cortex while following a reduced-calorie diet to support weight loss.

3 visits per week for 9 weeks

Follow-up

Duration - Up to 1 year after treatment

Participants return for weight measurements and assessments of behavioral and hormonal factors to monitor longer-term effects after treatment ends.

2 visits (at 6 months and 1 year post-treatment)

Trial Site Locations

Total: 1 location

1

NIDDK, Phoenix

Phoenix, Arizona, United States, 85014

Actively Recruiting

Loading map...

Research Team

K

Kat A Ware

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

5

Similar Trials

A Bilingual Virtually-based Intervention (PEDALL) for the Pr...

Acute Lymphoblastic Leukemia

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Neuromodulation targeted to the prefrontal cortex induces changes in energy intake and weight loss in obesity.

Marci E Gluck, Miguel Alonso-Alonso, Paolo Piaggi...

https://pubmed.ncbi.nlm.nih.gov/26530931

Less activation in the left dorsolateral prefrontal cortex in the reanalysis of the response to a meal in obese than in lean women and its association with successful weight loss.

Duc Son Nt Le, Nicola Pannacciulli, Kewei Chen...

https://pubmed.ncbi.nlm.nih.gov/17823419

Neuromodulation directed at the prefrontal cortex of subjects with obesity reduces snack food intake and hunger in a randomized trial.

Sascha Heinitz, Martin Reinhardt, Paolo Piaggi...

https://pubmed.ncbi.nlm.nih.gov/29046305

Improved food Go/No-Go scores after transcranial direct current stimulation (tDCS) to prefrontal cortex in a randomized trial.

Emma J Stinson, Katherine T Travis, Greta Magerowski...

https://pubmed.ncbi.nlm.nih.gov/36052819